Cumberland Pharmaceuticals Inc SEC filings CPIX

Cumberland Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Mar 18, 2009. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Mar 12, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Cumberland Pharmaceuticals Inc SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Oct 26, 2026 Oct 26, 2026
8-K Current report
Other events
Oct 23, 2026 Oct 23, 2026
8-K/A Amended current report
Shareholder vote results
Sep 11, 2026 Apr 21, 2026
8-K Current report
Regulation FD disclosure
Aug 28, 2026 Aug 28, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report
Other events
Jul 13, 2026 Jul 13, 2026
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Officer or director change, Other events
Jul 1, 2026 Jun 29, 2026
8-K Current report
Shareholder vote results
Jun 25, 2026 Jun 24, 2026
DEFM14A Filing May 26, 2026 —
PREM14A Filing May 15, 2026 May 15, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
8-K Current report
Shareholder vote results
Apr 24, 2026 Apr 21, 2026
DEFA14A Additional proxy material Apr 23, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Apr 23, 2026 Apr 22, 2026
ARS Annual report to shareholders Mar 12, 2026 Mar 12, 2026
DEFA14A Additional proxy material Mar 9, 2026 —
DEF 14A Proxy statement Mar 9, 2026 Dec 31, 2025
10-K Annual report Mar 9, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 3, 2026 Mar 3, 2026
8-K Current report
Other events
Feb 4, 2026 Feb 4, 2026
8-K Current report
Material agreement, New debt
Nov 24, 2025 Nov 18, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
8-K Current report
Other events
Oct 21, 2025 Oct 21, 2025
UPLOAD Letter from the SEC Aug 25, 2025 —
CORRESP Letter to the SEC Aug 15, 2025 —
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
UPLOAD Letter from the SEC Aug 4, 2025 —
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
8-K Current report
Shareholder vote results
Apr 28, 2025 Apr 28, 2025
8-K Current report
Other events
Mar 19, 2025 Mar 19, 2025
ARS Annual report to shareholders Mar 18, 2025 Mar 18, 2025
DEFA14A Additional proxy material Mar 10, 2025 —
DEF 14A Proxy statement Mar 10, 2025 Dec 31, 2024
10-K Annual report Mar 7, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 4, 2025 Mar 4, 2025
8-K Current report
Other events
Feb 19, 2025 Feb 19, 2025
424B5 Prospectus supplement Feb 14, 2025 —
8-K Current report
Other events
Feb 14, 2025 Feb 14, 2025
8-K Current report
Other events
Feb 4, 2025 Feb 4, 2025
8-K Current report
Other events
Dec 9, 2024 Dec 9, 2024
8-K Current report
Other events
Nov 12, 2024 Nov 6, 2024
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Other events
Nov 6, 2024 Nov 6, 2024
8-K Current report
Other events
Nov 4, 2024 Nov 4, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
8-K Current report
Shareholder vote results
Apr 29, 2024 Apr 29, 2024
ARS Annual report to shareholders Mar 22, 2024 Dec 31, 2023
8-K Current report
Other events
Mar 20, 2024 Mar 20, 2024
424B5 Prospectus supplement Mar 20, 2024 —
DEFA14A Additional proxy material Mar 13, 2024 —
DEF 14A Proxy statement Mar 13, 2024 Dec 31, 2023
10-K Annual report Mar 13, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 5, 2024 Mar 5, 2024
EFFECT Filing Dec 26, 2023 —
CORRESP Letter to the SEC Dec 21, 2023 —
UPLOAD Letter from the SEC Dec 19, 2023 —
DEL AM Filing Dec 15, 2023 —
S-3 Shelf registration Dec 14, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Other events
Oct 13, 2023 Oct 13, 2023
8-K Current report
Material agreement, Agreement ended, New debt
Sep 6, 2023 Sep 5, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Other events
Jun 30, 2023 Jun 26, 2023
8-K Current report
Other events
Jun 22, 2023 Jun 16, 2023
8-K Current report
Other events
Jun 7, 2023 Jun 2, 2023
8-K Current report
Auditor change
Jun 2, 2023 May 30, 2023
8-K Current report
Auditor change
May 24, 2023 May 24, 2023
8-K Current report
Other events
May 16, 2023 May 16, 2023
S-8 Employee stock plan registration May 16, 2023 —
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Shareholder vote results
Apr 28, 2023 Apr 25, 2023
8-K Current report
Other events
Apr 17, 2023 Apr 14, 2023
8-K Current report
Other events
Apr 4, 2023 Apr 4, 2023
ARS Annual report to shareholders Mar 22, 2023 Mar 22, 2023
DEFA14A Additional proxy material Mar 15, 2023 —
DEF 14A Proxy statement Mar 15, 2023 Mar 15, 2023
8-K Current report
Officer or director change
Mar 15, 2023 Mar 15, 2023
10-K Annual report Mar 13, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 7, 2023 Mar 7, 2023
8-K Current report
Officer or director change
Jan 17, 2023 Jan 17, 2023
8-K Current report
Other events
Dec 12, 2022 Dec 6, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Officer or director change
Jul 19, 2022 Jul 19, 2022
8-K Current report
Officer or director change
Jun 3, 2022 Jun 3, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
8-K Current report
Shareholder vote results
May 3, 2022 May 3, 2022
8-K Current report
Other events
Apr 25, 2022 Apr 25, 2022
8-K Current report
Officer or director change
Mar 22, 2022 Mar 22, 2022
8-K/A Amended current report Mar 17, 2022 Mar 17, 2022
8-K Current report
Officer or director change
Mar 17, 2022 Mar 17, 2022
DEF 14A Proxy statement Mar 16, 2022 Apr 28, 2022
10-K Annual report Mar 11, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 8, 2022 Mar 8, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Jan 6, 2022 Jan 6, 2022
8-K Current report
Material agreement
Jan 3, 2022 Dec 31, 2021
8-K Current report
Other events
Dec 27, 2021 Dec 27, 2021
424B5 Prospectus supplement Dec 27, 2021 —
8-K Current report
Other events
Dec 1, 2021 Nov 30, 2021
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Nov 19, 2021 Nov 19, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
8-K Current report
Material agreement
Nov 1, 2021 Nov 1, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 10, 2021 Aug 10, 2021
8-K Current report
Material agreement
Jun 14, 2021 Jun 11, 2021
8-K Current report
Officer or director change
May 14, 2021 May 14, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 11, 2021 May 11, 2021
8-K Current report
Shareholder vote results
Apr 30, 2021 Apr 30, 2021
DEF 14A Proxy statement Mar 15, 2021 Apr 27, 2021
10-K Annual report Mar 12, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 9, 2021 Mar 9, 2021
EFFECT Filing Jan 8, 2021 —
CORRESP Letter to the SEC Jan 6, 2021 —
UPLOAD Letter from the SEC Dec 16, 2020 —
S-3 Shelf registration Dec 11, 2020 —
8-K Current report
Other events
Dec 10, 2020 Dec 10, 2020
10-Q Quarterly report Nov 13, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 10, 2020 Nov 10, 2020
UPLOAD Letter from the SEC Oct 20, 2020 —
CORRESP Letter to the SEC Oct 16, 2020 —
8-K Current report
Material agreement
Oct 9, 2020 Oct 9, 2020
UPLOAD Letter from the SEC Sep 23, 2020 —
CORRESP Letter to the SEC Sep 18, 2020 —
10-Q Quarterly report Aug 14, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 11, 2020 Aug 11, 2020
10-Q/A Amended quarterly report Jul 24, 2020 Mar 31, 2020
CORRESP Letter to the SEC Jul 22, 2020 —
UPLOAD Letter from the SEC Jul 8, 2020 —
8-K Current report
Other events
May 29, 2020 May 29, 2020
10-Q Quarterly report May 22, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 20, 2020 May 20, 2020
8-K Current report
Other events
May 8, 2020 May 8, 2020
8-K Current report
Officer or director change, Shareholder vote results
May 8, 2020 May 8, 2020
8-K Current report
Auditor change
May 1, 2020 May 1, 2020
8-K Current report
Material agreement, New debt
Apr 21, 2020 Apr 21, 2020
DEF 14A Proxy statement Mar 20, 2020 May 5, 2020
10-K Annual report Mar 20, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 18, 2020 Mar 18, 2020
8-K Current report
Other events
Jan 10, 2020 Jan 10, 2020
8-K Current report
Acquisition or sale of assets
Jan 3, 2020 Jan 3, 2020
8-K Current report
Other events
Dec 6, 2019 Dec 6, 2019
8-K Current report
Other events
Nov 29, 2019 Nov 25, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
8-K Current report
Other events
Oct 18, 2019 Oct 15, 2019
8-K Current report
Other events
Sep 27, 2019 Sep 27, 2019
8-K Current report
Officer or director change
Sep 20, 2019 Sep 20, 2019
8-K Current report
Other events
Sep 11, 2019 Sep 11, 2019
8-K Current report
Other events
Sep 10, 2019 Sep 10, 2019
8-K Current report
Other events
Aug 23, 2019 Aug 23, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 14, 2019 Aug 14, 2019
10-Q Quarterly report May 15, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 14, 2019 May 14, 2019
8-K Current report
Shareholder vote results
Apr 26, 2019 Apr 26, 2019
DEF 14A Proxy statement Mar 14, 2019 Apr 23, 2019
10-K Annual report Mar 12, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 26, 2019 Feb 26, 2019
8-K Current report
Other events
Jan 28, 2019 Jan 28, 2019
8-K/A Amended current report Jan 28, 2019 Nov 16, 2018
8-K Current report
Other events
Jan 24, 2019 Jan 24, 2019
8-K Current report
Other events
Jan 14, 2019 Jan 11, 2019
CT ORDER Filing Dec 20, 2018 —
8-K Current report
Material agreement
Dec 7, 2018 Dec 7, 2018
8-K Current report
Acquisition or sale of assets
Nov 16, 2018 Nov 16, 2018
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 13, 2018 Nov 13, 2018
8-K Current report
Material agreement, Regulation FD disclosure
Nov 6, 2018 Nov 6, 2018
8-K Current report
Material agreement, New debt
Oct 19, 2018 Oct 19, 2018
8-K Current report
Other events
Oct 1, 2018 Oct 1, 2018
8-K Current report
Officer or director change
Sep 21, 2018 Sep 21, 2018
8-K Current report
Results of operations
Aug 14, 2018 Aug 14, 2018
10-Q Quarterly report Aug 14, 2018 Jun 30, 2018
8-K Current report
Other events
Aug 3, 2018 Aug 3, 2018
8-K Current report
Regulation FD disclosure
Jun 1, 2018 Jun 1, 2018
10-Q Quarterly report May 9, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 8, 2018 May 8, 2018
8-K Current report
Shareholder vote results
Apr 27, 2018 Apr 27, 2018
8-K Current report
Regulation FD disclosure
Apr 13, 2018 Apr 13, 2018
8-K Current report
Other events
Mar 30, 2018 Mar 30, 2018
8-K Current report
Other events
Mar 16, 2018 Mar 16, 2018
DEF 14A Proxy statement Mar 15, 2018 Apr 24, 2018
DEFA14A Additional proxy material Mar 15, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CPIX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
TN
Headquarters
Nashville,, TN
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1087294

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.